{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:03:14Z","timestamp":1791910994164,"version":"4.3.4"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1099163"],"award-info":[{"award-number":["1099163"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1041920"],"award-info":[{"award-number":["1041920"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1099163"],"award-info":[{"award-number":["1099163"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1099163"],"award-info":[{"award-number":["1099163"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1099163"],"award-info":[{"award-number":["1099163"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012256","name":"Cerebral Palsy Alliance Research Foundation","doi-asserted-by":"publisher","award":["IRG3113"],"award-info":[{"award-number":["IRG3113"]}],"id":[{"id":"10.13039\/100012256","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009727","name":"Hospital Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009727","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Genom. Med."],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cerebral palsy (CP) is the most common cause of childhood physical disability, with incidence between 1\/500 and 1\/700 births in the developed world. Despite increasing evidence for a major contribution of genetics to CP aetiology, genetic testing is currently not performed systematically. We assessed the diagnostic rate of genome sequencing (GS) in a clinically unselected cohort of 150 singleton CP patients, with CP confirmed at &gt;4 years of age. Clinical grade GS was performed on the proband and variants were filtered, and classified according to American College of Medical Genetics and Genomics\u2013Association for Molecular Pathology (ACMG-AMP) guidelines. Variants classified as pathogenic or likely pathogenic (P\/LP) were further assessed for their contribution to CP. In total, 24.7% of individuals carried a P\/LP variant(s) causing or increasing risk of CP, with 4.7% resolved by copy number variant analysis and 20% carrying single nucleotide or indel variants. A further 34.7% carried one or more rare, high impact variants of uncertain significance (VUS) in variation intolerant genes. Variants were identified in a heterogeneous group of genes, including genes associated with hereditary spastic paraplegia, clotting and thrombophilic disorders, small vessel disease, and other neurodevelopmental disorders. Approximately 1\/2 of individuals were classified as likely to benefit from changed clinical management as a result of genetic findings. In addition, no significant association between genetic findings and clinical factors was detectable in this cohort, suggesting that systematic sequencing of CP will be required to avoid missed diagnoses.<\/jats:p>","DOI":"10.1038\/s41525-021-00238-0","type":"journal-article","created":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T10:03:34Z","timestamp":1631786614000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Yield of clinically reportable genetic variants in unselected cerebral palsy by whole genome sequencing"],"prefix":"10.1038","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0345-9944","authenticated-orcid":false,"given":"C. L.","family":"van Eyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. L.","family":"Webber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. E.","family":"Minoche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1988-3005","authenticated-orcid":false,"given":"L. A.","family":"P\u00e9rez-Jurado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9298-3072","authenticated-orcid":false,"given":"M. A.","family":"Corbett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. E.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4446-7927","authenticated-orcid":false,"given":"J. G.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Harper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. H.","family":"MacLennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7884-6861","authenticated-orcid":false,"given":"J.","family":"Gecz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,16]]},"reference":[{"key":"238_CR1","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/dmcn.12080","volume":"55","author":"M Oskoui","year":"2013","unstructured":"Oskoui, M., Coutinho, F., Dykeman, J., Jett\u00e9, N. & Pringsheim, T. An update on the prevalence of cerebral palsy: a systematic review and meta-analysis. Dev. Med. Child Neurol. 55, 509\u2013519 (2013).","journal-title":"Dev. Med. Child Neurol."},{"key":"238_CR2","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1017\/S0012162200001511","volume":"42","author":"Surveillance of cerebral palsy in Europe.","year":"2000","unstructured":"Surveillance of cerebral palsy in Europe. a collaboration of cerebral palsy surveys and registers. Surveillance of Cerebral Palsy in Europe (SCPE). Dev. Med. Child Neurol. 42, 816\u2013824 (2000).","journal-title":"Dev. Med. Child Neurol."},{"key":"238_CR3","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1097\/AOG.0b013e31822ad2dc","volume":"118","author":"ME O\u2019Callaghan","year":"2011","unstructured":"O\u2019Callaghan, M. E. et al. Epidemiologic associations with cerebral palsy. Obstet. Gynecol. 118, 576\u2013582 (2011).","journal-title":"Obstet. Gynecol."},{"key":"238_CR4","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1097\/01.AOG.0000220544.21316.80","volume":"107","author":"EM Strijbis","year":"2006","unstructured":"Strijbis, E. M., Oudman, I., van Essen, P. & MacLennan, A. H. Cerebral palsy and the application of the international criteria for acute intrapartum hypoxia. Obstet. Gynecol. 107, 1357\u20131365 (2006).","journal-title":"Obstet. Gynecol."},{"key":"238_CR5","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1136\/bmj.317.7172.1554","volume":"317","author":"N Badawi","year":"1998","unstructured":"Badawi, N. et al. Intrapartum risk factors for newborn encephalopathy: the Western Australian case-control study. BMJ 317, 1554\u20131558 (1998).","journal-title":"BMJ"},{"key":"238_CR6","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/s41588-020-0695-1","volume":"52","author":"SC Jin","year":"2020","unstructured":"Jin, S. C. et al. Mutations disrupting neuritogenesis genes confer risk for cerebral palsy. Nat. Genet. 52, 1046\u20131056 (2020).","journal-title":"Nat. Genet."},{"key":"238_CR7","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/mp.2014.189","volume":"20","author":"G McMichael","year":"2015","unstructured":"McMichael, G. et al. Whole-exome sequencing points to considerable genetic heterogeneity of cerebral palsy. Mol. Psychiatry 20, 176\u2013182 (2015).","journal-title":"Mol. Psychiatry"},{"key":"238_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8949","volume":"6","author":"M Oskoui","year":"2015","unstructured":"Oskoui, M. et al. Clinically relevant copy number variations detected in cerebral palsy. Nat. Commun. 6, 7949 (2015).","journal-title":"Nat. Commun."},{"key":"238_CR9","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1093\/brain\/awv117","volume":"138","author":"R Parolin Schnekenberg","year":"2015","unstructured":"Parolin Schnekenberg, R. et al. De novo point mutations in patients diagnosed with ataxic cerebral palsy. Brain 138, 1817\u20131832 (2015).","journal-title":"Brain"},{"key":"238_CR10","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1212\/WNL.0000000000001494","volume":"84","author":"R Segel","year":"2015","unstructured":"Segel, R. et al. Copy number variations in cryptogenic cerebral palsy. Neurology 84, 1660\u20131668 (2015).","journal-title":"Neurology"},{"key":"238_CR11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41525-018-0073-4","volume":"3","author":"MA Corbett","year":"2018","unstructured":"Corbett, M. A. et al. Pathogenic copy number variants that affect gene expression contribute to genomic burden in cerebral palsy. NPJ Genom. Med. 3, 33 (2018).","journal-title":"NPJ Genom. Med"},{"key":"238_CR12","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/acn3.551","volume":"5","author":"Y Takezawa","year":"2018","unstructured":"Takezawa, Y. et al. Genomic analysis identifies masqueraders of full-term cerebral palsy. Ann. Clin. Transl. Neurol. 5, 538\u2013551 (2018).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"238_CR13","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/gim.2017.83","volume":"20","author":"M Zarrei","year":"2018","unstructured":"Zarrei, M. et al. De novo and rare inherited copy-number variations in the hemiplegic form of cerebral palsy. Genet. Med. 20, 172\u2013180 (2018).","journal-title":"Genet. Med."},{"key":"238_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41525-019-0101-z","volume":"4","author":"CL van Eyk","year":"2019","unstructured":"van Eyk, C. L. et al. Targeted resequencing identifies genes with recurrent variation in cerebral palsy. npj Genom. Med. 4, 27 (2019).","journal-title":"npj Genom. Med."},{"key":"238_CR15","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1111\/dmcn.14585","volume":"62","author":"R Pham","year":"2020","unstructured":"Pham, R. et al. Definition and diagnosis of cerebral palsy in genetic studies: a systematic review. Dev. Med. Child Neurol. 62, 1024\u20131030 (2020).","journal-title":"Dev. Med. Child Neurol."},{"key":"238_CR16","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1111\/dmcn.14604","volume":"62","author":"A Leviton","year":"2020","unstructured":"Leviton, A. Identifying cerebral palsy phenotypes objectively. Dev. Med. Child Neurol. 62, 1006 (2020).","journal-title":"Dev. Med. Child Neurol."},{"key":"238_CR17","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1093\/hmg\/ddt669","volume":"23","author":"AC Lionel","year":"2013","unstructured":"Lionel, A. C. et al. Disruption of the ASTN2\/TRIM32 locus at 9q33.1 is a risk factor in males for autism spectrum disorders, ADHD and other neurodevelopmental phenotypes. Hum. Mol. Genet. 23, 2752\u20132768 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"238_CR18","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","volume":"36","author":"SX Ge","year":"2019","unstructured":"Ge, S. X., Jung, D. & Yao, R. ShinyGO: a graphical gene-set enrichment tool for animals and plants. Bioinformatics 36, 2628\u20132629 (2019).","journal-title":"Bioinformatics"},{"key":"238_CR19","doi-asserted-by":"publisher","first-page":"42900","DOI":"10.1074\/jbc.M112.414094","volume":"287","author":"MR Sapio","year":"2012","unstructured":"Sapio, M. R. et al. Naturally occurring carboxypeptidase A6 mutations: effect on enzyme function and association with epilepsy. J. Biol. Chem. 287, 42900\u201342909 (2012).","journal-title":"J. Biol. Chem."},{"key":"238_CR20","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/s41431-020-00742-4","volume":"29","author":"I Garagiola","year":"2020","unstructured":"Garagiola, I. et al. X Chromosome inactivation: a modifier of factor VIII and IX plasma levels and bleeding phenotype in Haemophilia carriers. Eur. J. Hum. Genet. 29, 241\u2013249 (2020).","journal-title":"Eur. J. Hum. Genet."},{"key":"238_CR21","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.ajhg.2017.09.001","volume":"101","author":"M Quinodoz","year":"2017","unstructured":"Quinodoz, M. et al. DOMINO: using machine learning to predict genes associated with dominant disorders. Am. J. Hum. Genet. 101, 623\u2013629 (2017).","journal-title":"Am. J. Hum. Genet."},{"key":"238_CR22","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1126\/science.1227764","volume":"338","author":"BJ O\u2019Roak","year":"2012","unstructured":"O\u2019Roak, B. J. et al. Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science 338, 1619\u20131622 (2012).","journal-title":"Science"},{"key":"238_CR23","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s10038-019-0561-0","volume":"64","author":"H Yasin","year":"2019","unstructured":"Yasin, H. et al. A distinct neurodevelopmental syndrome with intellectual disability, autism spectrum disorder, characteristic facies, and macrocephaly is caused by defects in CHD8. J. Hum. Genet. 64, 271\u2013280 (2019).","journal-title":"J. Hum. Genet."},{"key":"238_CR24","doi-asserted-by":"publisher","first-page":"5043","DOI":"10.1128\/MCB.23.14.5043-5055.2003","volume":"23","author":"D Thumkeo","year":"2003","unstructured":"Thumkeo, D. et al. Targeted disruption of the mouse rho-associated kinase 2 gene results in intrauterine growth retardation and fetal death. Mol. Cell Biol. 23, 5043\u20135055 (2003).","journal-title":"Mol. Cell Biol."},{"key":"238_CR25","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/gim.2014.210","volume":"17","author":"ME Meuwissen","year":"2015","unstructured":"Meuwissen, M. E. et al. The expanding phenotype of COL4A1 and COL4A2 mutations: clinical data on 13 newly identified families and a review of the literature. Genet. Med. 17, 843\u2013853 (2015).","journal-title":"Genet. Med."},{"key":"238_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06618-y","volume":"9","author":"G Ahlberg","year":"2018","unstructured":"Ahlberg, G. et al. Rare truncating variants in the sarcomeric protein titin associate with familial and early-onset atrial fibrillation. Nat. Commun. 9, 4316 (2018).","journal-title":"Nat. Commun."},{"key":"238_CR27","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1136\/jmedgenet-2013-102100","volume":"51","author":"A Ta-Shma","year":"2014","unstructured":"Ta-Shma, A. et al. Conotruncal malformations and absent thymus due to a deleterious NKX2-6 mutation. J. Med. Genet. 51, 268\u2013270 (2014).","journal-title":"J. Med. Genet."},{"key":"238_CR28","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1093\/hmg\/ddi055","volume":"14","author":"K Heathcote","year":"2005","unstructured":"Heathcote, K. et al. Common arterial trunk associated with a homeodomain mutation of NKX2.6. Hum. Mol. Genet. 14, 585\u2013593 (2005).","journal-title":"Hum. Mol. Genet"},{"key":"238_CR29","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.ejmg.2014.08.005","volume":"57","author":"L Zhao","year":"2014","unstructured":"Zhao, L. et al. Prevalence and spectrum of Nkx2.6 mutations in patients with congenital heart disease. Eur. J. Med. Genet. 57, 579\u2013586 (2014).","journal-title":"Eur. J. Med. Genet."},{"key":"238_CR30","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.3892\/ijmm.2014.1971","volume":"34","author":"J Wang","year":"2014","unstructured":"Wang, J. et al. NKX2-6 mutation predisposes to familial atrial fibrillation. Int J. Mol. Med. 34, 1581\u20131590 (2014).","journal-title":"Int J. Mol. Med"},{"key":"238_CR31","first-page":"357","volume":"25","author":"BU Nwosu","year":"2012","unstructured":"Nwosu, B. U., Adhami S., Fau, Rogol, A. D. & Rogol, A. D. Stroke in a child with Adams-Oliver syndrome and mixed diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome. J. Pediatr. Endocrinol. Metab. 25, 357\u2013361 (2012).","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"238_CR32","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1002\/ajmg.a.32708","volume":"149A","author":"KM Snape","year":"2009","unstructured":"Snape, K. M. et al. The spectra of clinical phenotypes in aplasia cutis congenita and terminal transverse limb defects. Am. J. Med. Genet. A 149A, 1860\u20131881 (2009).","journal-title":"Am. J. Med. Genet. A"},{"key":"238_CR33","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1002\/ajmg.a.36486","volume":"164A","author":"M Isrie","year":"2014","unstructured":"Isrie, M., Wuyts, W., Van Esch, H. & Devriendt, K. Isolated terminal limb reduction defects: extending the clinical spectrum of Adams-Oliver syndrome and ARHGAP31 mutations. Am. J. Med. Genet. A 164A, 1576\u20131579 (2014).","journal-title":"Am. J. Med. Genet. A"},{"key":"238_CR34","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1399-0004.2012.01896.x","volume":"83","author":"E S\u00e1nchez-Ferrero","year":"2013","unstructured":"S\u00e1nchez-Ferrero, E. et al. SPG7 mutational screening in spastic paraplegia patients supports a dominant effect for some mutations and a pathogenic role for p.A510V. Clin. Genet. 83, 257\u2013262 (2013).","journal-title":"Clin. Genet."},{"key":"238_CR35","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1093\/brain\/aws240","volume":"135","author":"S Klebe","year":"2012","unstructured":"Klebe, S. et al. Spastic paraplegia gene 7 in patients with spasticity and\/or optic neuropathy. Brain 135, 2980\u20132993 (2012).","journal-title":"Brain"},{"key":"238_CR36","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1001\/jama.2020.26148","volume":"325","author":"A Moreno-De-Luca","year":"2021","unstructured":"Moreno-De-Luca, A. et al. Molecular Diagnostic Yield of Exome Sequencing in Patients With Cerebral Palsy. JAMA 325, 467\u2013475 (2021).","journal-title":"JAMA"},{"key":"238_CR37","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s12017-014-8331-9","volume":"16","author":"RW Lee","year":"2014","unstructured":"Lee, R. W. et al. A Diagnostic Approach for Cerebral Palsy in the Genomic Era. NeuroMolecular Med. 16, 821\u2013844 (2014).","journal-title":"NeuroMolecular Med."},{"key":"238_CR38","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1001\/archneur.63.3.445","volume":"63","author":"S Rainier","year":"2006","unstructured":"Rainier, S., Sher, C., Reish, O., Thomas, D. & Fink, J. K. De novo occurrence of novel SPG3A\/atlastin mutation presenting as cerebral palsy. Arch. Neurol. 63, 445\u2013447 (2006).","journal-title":"Arch. Neurol."},{"key":"238_CR39","doi-asserted-by":"publisher","first-page":"625428","DOI":"10.3389\/fneur.2020.625428","volume":"11","author":"SA Lewis","year":"2021","unstructured":"Lewis, S. A. et al. Insights From Genetic Studies of Cerebral Palsy. Front. Neurol. 11, 625428 (2021).","journal-title":"Front. Neurol."},{"key":"238_CR40","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.2174\/092986710790936293","volume":"17","author":"I Volonghi","year":"2010","unstructured":"Volonghi, I. et al. Role of COL4A1 in basement-membrane integrity and cerebral small-vessel disease. The COL4A1 stroke syndrome. Curr. Med. Chem. 17, 1317\u20131324 (2010).","journal-title":"Curr. Med. Chem."},{"key":"238_CR41","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/cge.12723","volume":"90","author":"D Bi","year":"2016","unstructured":"Bi, D. et al. Association of COL4A1 gene polymorphisms with cerebral palsy in a Chinese Han population. Clin. Genet. 90, 149\u2013155 (2016).","journal-title":"Clin. Genet"},{"key":"238_CR42","doi-asserted-by":"publisher","first-page":"103825","DOI":"10.1016\/j.ejmg.2019.103825","volume":"63","author":"K Kinoshita","year":"2020","unstructured":"Kinoshita, K. et al. De novo p.G696S mutation in COL4A1 causes intracranial calcification and late-onset cerebral hemorrhage: a case report and review of the literature. Eur. J. Med. Genet. 63, 103825 (2020).","journal-title":"Eur. J. Med. Genet."},{"key":"238_CR43","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.pediatrneurol.2016.04.010","volume":"66","author":"S Durrani-Kolarik","year":"2017","unstructured":"Durrani-Kolarik, S., Manickam, K. & Chen, B. COL4A1 Mutation in a Neonate With Intrauterine Stroke and Anterior Segment Dysgenesis. Pediatr. Neurol. 66, 100\u2013103 (2017).","journal-title":"Pediatr. Neurol."},{"key":"238_CR44","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1002\/ajmg.a.37527","volume":"170","author":"TT Ha","year":"2016","unstructured":"Ha, T. T. et al. A mutation in COL4A2 causes autosomal dominant porencephaly with cataracts. Am. J. Med. Genet. A 170, 1059\u20131063 (2016).","journal-title":"Am. J. Med. Genet. A"},{"key":"238_CR45","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/pr.2013.195","volume":"75","author":"LR Ment","year":"2014","unstructured":"Ment, L. R. et al. Gene-environment interactions in severe intraventricular hemorrhage of preterm neonates. Pediatr. Res. 75, 241\u2013250 (2014).","journal-title":"Pediatr. Res."},{"key":"238_CR46","doi-asserted-by":"publisher","first-page":"e0128230","DOI":"10.1371\/journal.pone.0128230","volume":"10","author":"HE Yong","year":"2015","unstructured":"Yong, H. E. et al. Genome-wide transcriptome directed pathway analysis of maternal pre-eclampsia susceptibility genes. PLoS ONE 10, e0128230 (2015).","journal-title":"PLoS ONE"},{"key":"238_CR47","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/1477-7827-1-111","volume":"1","author":"MJ Kupferminc","year":"2003","unstructured":"Kupferminc, M. J. Thrombophilia and pregnancy. Reprod. Biol. Endocrinol. 1, 111 (2003).","journal-title":"Reprod. Biol. Endocrinol."},{"key":"238_CR48","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/ng.3303","volume":"47","author":"N Krumm","year":"2015","unstructured":"Krumm, N. et al. Excess of rare, inherited truncating mutations in autism. Nat. Genet. 47, 582\u2013588 (2015).","journal-title":"Nat. Genet."},{"key":"238_CR49","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41588-019-0344-8","volume":"51","author":"J Grove","year":"2019","unstructured":"Grove, J. et al. Identification of common genetic risk variants for autism spectrum disorder. Nat. Genet. 51, 431\u2013444 (2019).","journal-title":"Nat. Genet."},{"key":"238_CR50","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/dmcn.12262","volume":"56","author":"H Smithers-Sheedy","year":"2014","unstructured":"Smithers-Sheedy, H. et al. What constitutes cerebral palsy in the twenty-first century? Dev. Med. Child Neurol. 56, 323\u2013328 (2014).","journal-title":"Dev. Med. Child Neurol."},{"key":"238_CR51","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ng.2892","volume":"46","author":"M Kircher","year":"2014","unstructured":"Kircher, M. et al. A general framework for estimating the relative pathogenicity of human genetic variants. Nat. Genet. 46, 310\u2013315 (2014).","journal-title":"Nat. Genet"},{"key":"238_CR52","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/nprot.2009.86","volume":"4","author":"P Kumar","year":"2009","unstructured":"Kumar, P., Henikoff, S. & Ng, P. C. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat. Protoc. 4, 1073\u20131081 (2009).","journal-title":"Nat. Protoc."},{"key":"238_CR53","doi-asserted-by":"publisher","unstructured":"Adzhubei, I., Jordan, D. M. & Sunyaev, S. R. Predicting functional effect of human missense mutations using PolyPhen-2. Curr. Protoc. Hum. Genet. 76:7.20.1\u20137.20.41. https:\/\/doi.org\/10.1002\/0471142905.hg0720s76 (2013).","DOI":"10.1002\/0471142905.hg0720s76"},{"key":"238_CR54","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nmeth0810-575","volume":"7","author":"JM Schwarz","year":"2010","unstructured":"Schwarz, J. M., R\u00f6delsperger, C., Schuelke, M. & Seelow, D. MutationTaster evaluates disease-causing potential of sequence alterations. Nat. Methods 7, 575\u2013576 (2010).","journal-title":"Nat. Methods"},{"key":"238_CR55","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1093\/hmg\/ddu733","volume":"24","author":"C Dong","year":"2015","unstructured":"Dong, C. et al. Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies. Hum. Mol. Genet. 24, 2125\u20132137 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"238_CR56","doi-asserted-by":"publisher","first-page":"e1001025","DOI":"10.1371\/journal.pcbi.1001025","volume":"6","author":"EV Davydov","year":"2010","unstructured":"Davydov, E. V. et al. Identifying a high fraction of the human genome to be under selective constraint using GERP. PLoS Comput. Biol. 6, e1001025 (2010).","journal-title":"PLoS Comput. Biol."},{"key":"238_CR57","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","volume":"176","author":"K Jaganathan","year":"2019","unstructured":"Jaganathan, K. et al. Predicting Splicing from Primary Sequence with Deep Learning. Cell 176, 535\u2013548 e24 (2019).","journal-title":"Cell"},{"key":"238_CR58","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1093\/nar\/gkp215","volume":"37","author":"FO Desmet","year":"2009","unstructured":"Desmet, F. O. et al. Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res. 37, e67 (2009).","journal-title":"Nucleic Acids Res."},{"key":"238_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-021-00841-x","volume":"13","author":"AE Minoche","year":"2021","unstructured":"Minoche, A. E. et al. ClinSV: clinical grade structural and copy number variant detection from whole genome sequencing data. Genom. Med. 13, 32 (2021).","journal-title":"Genom. Med."},{"key":"238_CR60","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1101\/gr.114876.110","volume":"21","author":"A Abyzov","year":"2011","unstructured":"Abyzov, A., Urban, A. E., Snyder, M. & Gerstein, M. CNVnator: an approach to discover, genotype, and characterize typical and atypical CNVs from family and population genome sequencing. Genom. Res. 21, 974\u2013984 (2011).","journal-title":"Genom. Res."},{"key":"238_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2014-15-6-r84","volume":"15","author":"RM Layer","year":"2014","unstructured":"Layer, R. M., Chiang, C., Quinlan, A. R. & Hall, I. M. LUMPY: a probabilistic framework for structural variant discovery. Genom. Biol. 15, R84 (2014).","journal-title":"Genom. Biol."},{"key":"238_CR62","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41431-018-0279-z","volume":"27","author":"P Lacaze","year":"2019","unstructured":"Lacaze, P. et al. The Medical Genome Reference Bank: a whole-genome data resource of 4000 healthy elderly individuals. Rationale and cohort design. Eur. J. Hum. Genet. 27, 308\u2013316 (2019).","journal-title":"Eur. J. Hum. Genet."},{"key":"238_CR63","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405\u2013423 (2015).","journal-title":"Genet. Med."},{"key":"238_CR64","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1101\/gr.6861907","volume":"17","author":"K Wang","year":"2007","unstructured":"Wang, K. et al. PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genom. Res. 17, 1665\u20131674 (2007).","journal-title":"Genom. Res."},{"key":"238_CR65","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen, T. D. & Livak, K. J. Analyzing real-time PCR data by the comparative CT method. Nat. Protoc. 3, 1101\u20131108 (2008).","journal-title":"Nat. Protoc."},{"key":"238_CR66","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1100\/tsw.2010.195","volume":"10","author":"M Marcinkowska","year":"2010","unstructured":"Marcinkowska, M. et al. Design and generation of MLPA probe sets for combined copy number and small-mutation analysis of human genes: EGFR as an example. Sci. World J. 10, 2003\u20132018 (2010).","journal-title":"Sci. World J."},{"key":"238_CR67","doi-asserted-by":"publisher","first-page":"S609","DOI":"10.1016\/j.ajog.2017.12.011","volume":"218","author":"J Gardosi","year":"2018","unstructured":"Gardosi, J., Francis, A., Turner, S. & Williams, M. Customized growth charts: rationale, validation and clinical benefits. Am. J. Obstet. Gynecol. 218, S609\u2013S618 (2018).","journal-title":"Am. J. Obstet. Gynecol."}],"container-title":["npj Genomic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41525-021-00238-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41525-021-00238-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41525-021-00238-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T20:53:35Z","timestamp":1670014415000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41525-021-00238-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,16]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["238"],"URL":"https:\/\/doi.org\/10.1038\/s41525-021-00238-0","relation":{},"ISSN":["2056-7944"],"issn-type":[{"value":"2056-7944","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,16]]},"assertion":[{"value":"27 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"74"}}